Site Editors

Robert I. Haddad, MD

Lori J. Wirth, MD

Advertisement

Advertisement

Videos

Giuseppe Curigliano, MD, PhD, on NSCLC and Thyroid Cancer: Treatment With a Selective RET Inhibitor

Medical Literature

Minimizing Overdiagnosis and Overtreatment in Patients With Thyroid Nodules

News

Can Digoxin Improve RAI Sensitivity in Resistant Nonmedullary Thyroid Cancer?

Medical Literature

BRAF V600E Mutations and Recurrence of Papillary Thyroid Carcinomas

News

Are Physicians Confident in Ultrasonography’s Ability to Detect Thyroid Cancer Recurrence?

Medical Literature

What Makes for a Successful Thyroid Cancer Active Surveillance Program?

Medical Literature

Rare Case of Primary Squamous Cell Carcinoma of the Thyroid

Enrique Grande, MD, PhD, on Targeted Treatment for Thyroid Cancer

Lori J. Wirth, MD, on Selpercatinib, Medullary Thyroid Cancer, and Diarrhea

View More

Advertisement

JNCCN Spotlights

Dabrafenib + Trametinib (Anaplastic Thyroid Cancer)

Selpercatinib (Retevmo™)

View More

More

News

PSMA PET: A Potential Theranostic Agent in Thyroid Cancer?

Simultaneous Primary Hyperparathyroidism and Thyroid Carcinomas: Rare Case Study

ASTRO 2020: High-Dose Iodine-131 Ablation for High-Risk Thyroid Cancer

ESMO Asia 2020: Anlotinib in Radioiodine-Refractory Differentiated Thyroid Carcinoma

Are Serum Thyroglobulin Levels a Reliable Marker of Recurrence in Thyroid Cancer?

Potential Cardiovascular Risks of Thyroid Cancer Therapy and Hyperthyroidism

Are Physicians Confident in Ultrasonography’s Ability to Detect Thyroid Cancer Recurrence?

Case Report: Neoadjuvant Selpercatinib in RET‐Mutated Medullary Thyroid Cancer

View More

Advertisement

Published

Medical Literature

Using Carbon Nanoparticles to Map Lateral Neck Lymph Nodes in Papillary Thyroid Cancer

Total Versus Partial Thyroidectomy for Early-Stage Papillary Thyroid Cancer

Use of Opioids in Patients With Thyroid Cancer After Extensive Neck Dissection

Using AI to Determine the Genetic Risk of Thyroid Nodules

View More

Ongoing

CE Activities

Differentiated thyroid cancer (DTC): therapeutic updates and optimizing treatment

A Unique Approach to Assessing the Risk of Indeterminate Thyroid Nodules

Current and Emerging Treatment Options for Lung Cancer and Head & Neck Carcinoma

Is Radioiodine Tx Overused in Low-Risk Thyroid Cancer?

View More

Available

Clinical Trials

Memorial Sloan Kettering Memorial Center

Samuel Oschin Comprehensive Cancer Center

Yale Cancer Center

University of Michigan Rogel Cancer Center

View More

Resources

For Your Patients

ThyCa: Thyroid Cancer Survivors' Association, Inc.

American Thyroid Association

Rogel Cancer Center Thyroid Cancer Patient Resources

Light of Life Foundation

View More

Sections

360 Hub

NCCN Resources

Copyright^© 2021 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.